Alzheimer's disease and corticobasal degeneration presentingas corticobasal syndrome

Movement Disorders

Volumn 24, Issue 9, 2009, Pages 1375-1379

  Hu, William T ^a   Rippon, Gregory W ^b   Boeve, Bradley F ^a   Knopman, David S ^a   Petersen, Ronald C ^a   Parisi, Joseph E ^a   Josephs, Keith A ^a  

^a MAYO CLINIC   (United States)

^b CEPHALON INC   (United States)

Author keywords

AD; CBD; CBS; Parkinsonism; SPECT; Tau; Tauopathy

Indexed keywords

TECHNETIUM 99M;

ALZHEIMER DISEASE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; BRAIN RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; FEMALE; HUMAN; MALE; MEMORY DISORDER; MYOCLONUS; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; ONSET AGE; PERFUSION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; AUTOPSY; BASAL GANGLIA; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 69549085108     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22574     Document Type: Article

References (15)

1. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800.
2. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003;18:467-486.
3. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-125.
4. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain 2007;130 (Part 10):2636-2645.
5. Chand P, Grafman J, Dickson D, Ishizawa K, Litvan I. Alzheimer's disease presenting as corticobasal syndrome. Mov Disord 2006;21:2018-2022.
6. Doran M, du Plessis DG, Enevoldson TP, Fletcher NA, Ghadiali E, Larner AJ. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci 2003;216:127-134.
7. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006;66:41-48.
8. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003;54 (Suppl 5):S15-S19.
9. Ivnik RJ, Smith GE, Lucas JA, Tangalos EG, Kokmen E, Petersen RC. Free and cued selective reminding test: MOANS norms. J Clin Exp Neuropsychol 1997;19:676-691.
10. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997;56:1095-1097.
11. Hu WT, Josephs KA, Ahlskog JE, Shin C, Boeve BF, Witte RJ. MRI correlates of alien leg-like phenomenon in corticobasal degeneration. Mov Disord 2005;20:870-873.
12. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol 1991;48:725-728.
13. Litvan I, Grimes DA, Lang AE. Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. Adv Neurol 2000;82:183-196.
14. Vanvoorst WA, Greenaway MC, Boeve BF, et al. Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy. Parkinsonism Relat Disord 2008;14:376-378.
15. Rabinovici GD, Furst AJ, O'Neil JP, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007;68:1205-1212.